Merkel cell carcinoma: Our experience in this rare pathology
Med. oral patol. oral cir. bucal (Internet)
; 16(6): 736-739, sept. 2011. ilus
Article
en En
| IBECS
| ID: ibc-93081
Biblioteca responsable:
ES1.1
Ubicación: BNCS
ABSTRACT
Merkel cell carcinoma (MCC) was first described in 1972 by Toker, who described five cases of the so-calledtrabecular carcinoma of the skin. MCC is a rare, aggressive skin cancer that affects mainly the elderly. Sun exposedareas are mainly affected, specially the head and neck. Immunohistochemical analysis is essential to reacha correct diagnosis. According to the origin of MCC, the tumor expresses both epithelial and neuroendocrinemarkers. MCC has a propensity for recurrence, regional and distant metastases. Several treatment options areavailable, such as surgical excision or Mohs surgery, accompanied by neck dissection or radio and chemotherapyin advanced cases. The present study aims to evaluate the clinical behaviour and the evolution of five cases of thisdisease that were treated at our institution (reference to 1100000 inhabitants) in the last five years. It is stressed onthe bad prognosis of this pathology, which presents high rates of locoregional recurrence, even though the recentadvances in radio and chemotherapy (AU)
RESUMEN
No disponible
Buscar en Google
Colección:
06-national
/
ES
Base de datos:
IBECS
Asunto principal:
Carcinoma de Células de Merkel
/
Neoplasias de Cabeza y Cuello
Tipo de estudio:
Prognostic_studies
Límite:
Aged
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Med. oral patol. oral cir. bucal (Internet)
Año:
2011
Tipo del documento:
Article